Clinical Trial Update: Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating eltrombopag for severe, very severe, and moderate aplastic anemia reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Very Severe Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: University of Utah | Conditions: Severe Aplastic Anemia, Very Severe Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2017-10-19